365 Days of Progress In Cancer Molecular Targets and Therapeutics

70.8K

views

167

authors

23

articles

365 Days of Progress In Cancer Molecular Targets and Therapeutics

70.8K

views

167

authors

23

articles

Editors

2

Massimo Broggini

Wafik S. El-Deiry, MD, PhD, FACP

Impact

Fetching...

About

“365 Days of Progress” is part of a wider series of Research Topics across Frontiers in Oncology, hosted by our Specialty Chief Editors, showcasing popular articles from 2021 igniting interest in the field.

This Research Topic aims to highlight the work featured and spark further discussion. The Cancer Molecular Targets and Therapeutics field is continuously evolving, therefore we are seeking to understand developments and perspectives on articles that have attracted attention throughout the year.

We welcome Opinions, Perspectives, and Mini-Review article types to facilitate this discussion. We also welcome updated original data following the research featured in this collection. Please note only papers that are relevant and add a significant contribution to the discussion articles will be considered.

The chosen manuscripts are :

- Genomics-Guided Drawing of Molecular and Pathophysiological Components of Malignant Regulatory Signatures Reveals a Pivotal Role in Human Diseases of Stem Cell-Associated Retroviral Sequences and Functionally-Active hESC Enhancers

- Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges

- Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches

- CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents

- The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

- The Role of CD276 in Cancers

- Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies

- PPAR-a Modulators as Current and Potential Cancer Treatments

- Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers

- A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer

Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.

“365 Days of Progress” is part of a wider series of Research Topics across Frontiers in Oncology, hosted by our Specialty Chief Editors, showcasing popular articles from 2021 igniting interest in the field.

This Research Topic aims to highlight the work featured and spark further discussion. The Cancer Molecular Targets and Therapeutics field is continuously evolving, therefore we are seeking to understand developments and perspectives on articles that have attracted attention throughout the year.

We welcome Opinions, Perspectives, and Mini-Review article types to facilitate this discussion. We also welcome updated original data following the research featured in this collection. Please note only papers that are relevant and add a significant contribution to the discussion articles will be considered.

The chosen manuscripts are :

- Genomics-Guided Drawing of Molecular and Pathophysiological Components of Malignant Regulatory Signatures Reveals a Pivotal Role in Human Diseases of Stem Cell-Associated Retroviral Sequences and Functionally-Active hESC Enhancers

- Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges

- Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches

- CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents

- The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

- The Role of CD276 in Cancers

- Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies

- PPAR-a Modulators as Current and Potential Cancer Treatments

- Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers

- A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer

Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.

Download ebook

Share

Editors

Massimo Broggini

Wafik S. El-Deiry, MD, PhD, FACP

Impact

70,837 Total views

44,895 Article views

25,329 Article downloads

613 Topic views

Published In

Journal Thumbnail

Frontiers in Oncology

Cancer Molecular Targets and Therapeutics

Journal Thumbnail

Frontiers in Pharmacology

Cancer Molecular Targets and Therapeutics

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic